Marksans Pharma has entered into a settlement agreement with the holders of Foreign Currency Convertible Bonds (FCCBs) for settling US dollar 26,918,000 worth of FCCBs in principal value.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.